---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-112393"
form_type: "8-K"
ticker: "RVP"
cik: "0000946563"
company_name: "RETRACTABLE TECHNOLOGIES INC"
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T20:04:48.574628+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Retractable Q3 net sales $10.1M, operating loss $3.7M; receives Vizient designation

## Summary
- Q3 net sales $10.1M (down from $10.3M YoY); operating loss $3.7M vs $5.1M loss last year.
- Net income $371k in Q3 includes $2.4M unrealized gains on securities; 9-month net loss $10.2M.
- Tariffs on needles from China at 130%; $2.3M spent on tariffs in first nine months of 2025.
- U.S. manufacturing share rose to 38.3% in 2025 from 10% in 2024; workforce reductions implemented.
- EasyPoint Blood Collection Tube Holder with Needle received Vizient Innovative Technology designation.

## SEC filing metadata
- accession: 0001104659-25-112393
- form_type: 8-K
- ticker: RVP
- cik: 0000946563
- company_name: RETRACTABLE TECHNOLOGIES INC
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946563/000110465925112393/0001104659-25-112393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946563/000110465925112393/tm2531255d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-112393
- JSON: https://secwatch.observer/filing/0001104659-25-112393.json
- Plain text: https://secwatch.observer/filing/0001104659-25-112393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.